- Home
- CRDF vs CTEV Comparison
CRDF vs CTEV Comparison
Compare CRDF & CTEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- CTEV
- Stock Information
- Founded
- CRDF 1999
- CTEV 1980
- Country
- CRDF United States
- CTEV United States
- Employees
- CRDF N/A
- CTEV N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- CTEV
- Sector
- CRDF Health Care
- CTEV
- Exchange
- CRDF Nasdaq
- CTEV NYSE
- Market Cap
- CRDF 288.7M
- CTEV 295.8M
- IPO Year
- CRDF N/A
- CTEV N/A
- Fundamental
- Price
- CRDF $3.83
- CTEV $21.10
- Analyst Decision
- CRDF Strong Buy
- CTEV Hold
- Analyst Count
- CRDF 4
- CTEV 1
- Target Price
- CRDF $12.00
- CTEV $19.00
- AVG Volume (30 Days)
- CRDF 1.1M
- CTEV 147.3K
- Earning Date
- CRDF 05-01-2025
- CTEV 05-07-2025
- Dividend Yield
- CRDF N/A
- CTEV N/A
- EPS Growth
- CRDF N/A
- CTEV N/A
- EPS
- CRDF N/A
- CTEV N/A
- Revenue
- CRDF $683,000.00
- CTEV $930,624,000.00
- Revenue This Year
- CRDF N/A
- CTEV N/A
- Revenue Next Year
- CRDF N/A
- CTEV N/A
- P/E Ratio
- CRDF N/A
- CTEV N/A
- Revenue Growth
- CRDF 39.96
- CTEV N/A
- 52 Week Low
- CRDF $2.01
- CTEV $4.80
- 52 Week High
- CRDF $6.42
- CTEV $37.60
- Technical
- Relative Strength Index (RSI)
- CRDF 43.91
- CTEV N/A
- Support Level
- CRDF $3.52
- CTEV N/A
- Resistance Level
- CRDF $4.42
- CTEV N/A
- Average True Range (ATR)
- CRDF 0.29
- CTEV 0.00
- MACD
- CRDF -0.04
- CTEV 0.00
- Stochastic Oscillator
- CRDF 18.89
- CTEV 0.00
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").
About CTEV CLARITEV CORPORATION
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.